Want to see DMRA full AI Analyst Report?
Damora Therapeutics (DMRA) Stock Forecast & Price Target
DMRA Analyst Ratings
DMRA Stock 12 Month Forecast
Average Price Target
$47.14▲(115.66% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Mitchell Kapoor | H.C. Wainwright | $45 | buy | 105.86%Upside | Reiterated | 11/05/26 | ||
| Andrew Berens | Leerink Partners | $51 | buy | 133.30%Upside | Reiterated | 11/05/26 | ||
| David Nierengarten | Wedbush | $40 | buy | 82.98%Upside | Reiterated | 11/05/26 | ||
| Bradley Canino | Guggenheim | $60→$59 | buy | 169.90%Upside | Reiterated | 11/05/26 | ||
| Brian Abrahams | RBC Capital | $40 | buy | 82.98%Upside | Reiterated | 11/04/26 | ||
| Sam Slutsky | LifeSci Capital | $45 | buy | 105.86%Upside | Reiterated | 09/18/26 | ||
| Akash Tewari | Jefferies | $50 | buy | 128.73%Upside | Reiterated | 08/11/26 | ||
| Marc Frahm | TD Cowen | ― | buy | ― | Reiterated | 08/10/26 | ||
| Gavin Clark-Gartner | Evercore ISI | $46 | buy | 110.43%Upside | Initiated | 03/25/26 | ||
| Michael Yee | UBS | $45 | buy | 105.86%Upside | Initiated | 02/17/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Mitchell KapoorH.C. Wainwright | BuyReiterated$45 | 11/05/26 | 105.86%Upside | ||
| Andrew BerensLeerink Partners | BuyReiterated$51 | 11/05/26 | 133.30%Upside | ||
| David NierengartenWedbush | BuyReiterated$40 | 11/05/26 | 82.98%Upside | ||
| Bradley CaninoGuggenheim | BuyReiterated$60→$59 | 11/05/26 | 169.90%Upside | ||
| Brian AbrahamsRBC Capital | BuyReiterated$40 | 11/04/26 | 82.98%Upside | ||
| Sam SlutskyLifeSci Capital | BuyReiterated$45 | 09/18/26 | 105.86%Upside | ||
| Akash TewariJefferies | BuyReiterated$50 | 08/11/26 | 128.73%Upside | ||
| Marc FrahmTD Cowen | BuyReiterated | 08/10/26 | ― | ||
| Gavin Clark-GartnerEvercore ISI | BuyInitiated$46 | 03/25/26 | 110.43%Upside | ||
| Michael YeeUBS | BuyInitiated$45 | 02/17/26 | 105.86%Upside |
Best Analysts Covering Damora Therapeutics
Copying Bradley Canino's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +18.38% per trade.
Copying Bradley Canino's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.82% per trade.
Copying Bradley Canino's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.82% per trade.
DMRA Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 11 | 9 | 6 | 5 | 8 |
| Buy | 5 | 11 | 9 | 7 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 20 | 15 | 12 | 8 |
In the current month, DMRA has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DMRA average Analyst price target in the past 3 months is 47.14.
DMRA Financial Forecast
DMRA Earnings Forecast
Next quarter’s earnings estimate for DMRA is -$0.55 with a range of -$0.83 to -$0.40. The previous quarter’s EPS was -$0.40. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
DMRA Sales Forecast
Next quarter’s sales forecast for DMRA is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
